Because Pf4 is known to be released during platelet activation, we analyzed blood platelets count at (1) baseline, (2) after the exercise training protocol and before tumor cell injection, and (3) after 10 days of CT26 cells injection. This evidence concerns the gene PF4 and neoplasm.